LeMaitre continues to expand in the peripheral vascular disease market, with recent revenue gains driven by premium pricing and international growth. Its strong dividend growth of 14.3% this year ...
LeMaitre Vascular Inc. (LMAT)股价已达到令人印象深刻的里程碑,飙升至106.78美元的历史新高。这一峰值反映了投资者信心的显著增强,从公司近一年97.17%的惊人涨幅中可见一斑,股价几乎翻倍。这家以创新血管外科产品闻名的医疗设备公司正经历一段强劲增长期,吸引了行业分析师和投资者的关注。这一历史新高为LeMaitre ...
A large exercise of company stock options by George LeMaitre, Chairman and CEO at LeMaitre Vascular LMAT was disclosed in a new SEC filing on November 26, as part of an insider exercise.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
LeMaitre Vascular Inc. (NASDAQ:LMAT)的董事Lawrence J. Jasinski最近出售了198股公司普通股。这笔交易发生于2024年11月20日,每股成交价为103.50美元,总价值约为20,493美元。此次出售后,Jasinski仍持有公司5,111股股份。这项交易已在提交给美国证券交易委员会的监管文件中披露。
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the company, Marketbeat reports.
Georges LeMaitre (1894-1966) showed that religion and science -- or at least physics -- did not have to be incompatible. LeMaitre, born in Belgium, was a monsignor in the Catholic church.
Welcome to the LeMaitre Vascular Q3 2024 Financial Results Conference Call. As a reminder, today's call is being recorded. At this time, I would like to turn the call over to Mr. J.J. Pellegrino ...
Pierre Lemaitre, trans. from the French by Frank Wynne. Quercus/MacLehose, $24.99 (448p) ISBN 978-1-62365-903-5 Winner of the Prix Goncourt, Lemaitre’s assured, somber exploration of post-WWI ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...